SLC1A5 and diabetes mellitus: Though strong evidence does not yet exist linking SLC1A5 to cardiovascular mechanisms, its CpGs have shown associations with diabetes, blood pressure, and mortality [50–52], and we note that its companion amino acid transporter, SLC7A5, is known to regulate metabolic and inflammatory reprogramming of monocytes in response to stimulation by lipopolysaccharide (LPS).